On Friday the 6th of July, Mar Hall Golf and Spa Resort played host to the 2018 Unite Against Cancer charity golf day.

44 golfers participated in our event on what turned out to be a scorching hot summer's day. 

Upon arrival guests were provided with tea, coffee and bacon rolls, followed by one of our Trustees Colin Smith welcoming guests and outlining the competition format.

There was a two tee start with six groups teeing off from t...


The University of Glasgow will lead an innovative Pan-European research training program targeting incurable prostate cancer.‌‌

The four-year Translational Research Network for Prostate Cancer (TransPot) aims to provide a multidisciplinary training program, integrating cancer biology and systems medicine to enable young researchers to become future leaders in cancer research.

A partnership between academic and industrial institutions in the UK, Finland,...


A ground-breaking new pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, is to begin in Scotland. 

Run by Precision-Panc, a research programme and clinical trials project led by the University of Glasgow, the trial will bring a precision medicine approach to pancreatic cancer treatment for the first time in the UK.

Pancreatic cancer is the 5th most common cause of cancer death in the UK wi...


On Sunday the 29th of October, 167 guests attended the inaugural Unite Against Cancer Ladies Lunch at the luxurious Boclair House Hotel. 

Michelle McManus was the MC and did an excellent job of hosting the event and amusing everyone with her sharp wit.

Elliot Bibby - Magicman entertained everyone with his magic skills.

ABBA MANIA performed for our guests and helped them dance the afternoon away.

A wonderful event in aid of a great cause, and mos...


The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research. ‌

The University of Glasgow led study, published today in Nature Medicine, demonstrates the effectiveness of combining tigecycline with the drug imatinib – a tyrosine kinase inhibitor (TKI) and standard first-line treatment of patients with CML.

Using cells isolated from CML patien...

Please reload


Unite Against Cancer SC043017 is a Scottish registered charity that raises money to fund research into new cancer treatments and to educate and inform on cancer prevention.

© 2018 by Unite Against Cancer.